Open Access

[Retracted] Isoquercitrin inhibits the progression of liver cancer in vivo and in vitro via the MAPK signalling pathway

  • Authors:
    • Guihong Huang
    • Bo Tang
    • Kun Tang
    • Xiaomin Dong
    • Jungang Deng
    • Luqin Liao
    • Zengzhen Liao
    • Hua Yang
    • Songqing He
  • View Affiliations

  • Published online on: February 28, 2023     https://doi.org/10.3892/or.2023.8510
  • Article Number: 73
  • Copyright : © Huang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

April-2023
Volume 49 Issue 4

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Huang G, Tang B, Tang K, Dong X, Deng J, Liao L, Liao Z, Yang H and He S: [Retracted] Isoquercitrin inhibits the progression of liver cancer <em>in vivo</em> and <em>in vitro</em> via the MAPK signalling pathway. Oncol Rep 49: 73, 2023
APA
Huang, G., Tang, B., Tang, K., Dong, X., Deng, J., Liao, L. ... He, S. (2023). [Retracted] Isoquercitrin inhibits the progression of liver cancer <em>in vivo</em> and <em>in vitro</em> via the MAPK signalling pathway. Oncology Reports, 49, 73. https://doi.org/10.3892/or.2023.8510
MLA
Huang, G., Tang, B., Tang, K., Dong, X., Deng, J., Liao, L., Liao, Z., Yang, H., He, S."[Retracted] Isoquercitrin inhibits the progression of liver cancer <em>in vivo</em> and <em>in vitro</em> via the MAPK signalling pathway". Oncology Reports 49.4 (2023): 73.
Chicago
Huang, G., Tang, B., Tang, K., Dong, X., Deng, J., Liao, L., Liao, Z., Yang, H., He, S."[Retracted] Isoquercitrin inhibits the progression of liver cancer <em>in vivo</em> and <em>in vitro</em> via the MAPK signalling pathway". Oncology Reports 49, no. 4 (2023): 73. https://doi.org/10.3892/or.2023.8510